KMO (Kynurenine 3-monoxygenase) Inhibitors

Our KMO (Kynurenine 3-monoxygenase) inhibitors are cutting-edge substances that have been developed to control the activity of the KMO enzyme which plays a crucial role in the metabolism of tryptophan an amino acid essential for various biological processes By inhibiting KMO our product is designed to modulate the kynurenine pathway a key biological pathway implicated in a range of neurological and psychiatric disorders Through precise and targeted inhibition our KMO inhibitors have the potential to provide therapeutic benefits in the treatment of these diseases

Catalog Number	Chemical Name	CAS #	Price
EI-1903	Ro 61-8048	199666-03-0	Online Inquiry

Application

KMO inhibitors have a range of promising applications in both research and medicine In the field of research these inhibitors are widely used to study the kynurenine pathway a metabolic pathway involved in the breakdown of tryptophan By inhibiting KMO scientists can gain a better understanding of how this pathway influences various biological processes such as inflammation neurodegeneration and psychiatric disorders

In medicine KMO inhibitors hold potential as therapeutic agents for the treatment of conditions associated with excessive activation of the kynurenine pathway For example in neurodegenerative diseases such as Alzheimer's and Parkinson's KMO inhibitors can help modulate the levels of neurotoxic metabolites produced in the pathway potentially slowing down disease progression

Furthermore KMO inhibitors have shown promise in the treatment of psychiatric disorders such as depression and schizophrenia where dysregulation of the kynurenine pathway has been implicated By blocking KMO these inhibitors can help restore the balance of neuroactive metabolites and potentially alleviate symptoms

Overall the applications of KMO inhibitors in both research and medicine offer exciting possibilities for understanding biological processes and developing targeted therapies for a range of diseases

Please note that all services are for research use only. Not intended for any clinical use.

KMO (Kynurenine 3-monoxygenase) Inhibitors